Second brazilian consensus on the treatment of advanced prostate cancer: a SBOC-SBU-SBRT panel review
Int. braz. j. urol
;
45(3): 449-458, May-June 2019. graf
Article
Dans Anglais
| LILACS
| ID: biblio-1012334
ABSTRACT
ABSTRACT Prostate cancer is the second most common cancer and the fifth leading cause of cancer deaths. In Brazil, it is likewise the second most common cancer among men, second only to non-melanoma skin cancers. The aim of this consensus is to align different opinions and interpretations of the medical literature in a practical and patient-oriented approach. The first Brazilian Consensus on the Treatment of Advanced Prostate Cancer was published in 2017, with the goal of reducing the heterogeneity of therapeutic conduct in Brazilian patients with metastatic prostate cancer. We acknowledge that in Brazil the incorporation of different technologies is a big challenge, especially in the Sistema Único de Saúde (SUS), which allows for the disparity in the options available to patients treated in different institutions. In order to update the recommendations and to make them objective and easily accessible, once more a panel of specialists was formed in order to discuss and elaborate a new Brazilian Consensus on Advanced Prostate Cancer. This Consensus was written through a joint initiative of the Brazilian Society of Clinical Oncology (SBOC) and the Brazilian Society of Urology (SBU) to support the clinical decisions of physicians and other health professionals involved in the care of patients with prostate cancer.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Tumeurs de la prostate
/
Guides de bonnes pratiques cliniques comme sujet
/
Consensus
Type d'étude:
Guide de pratique
/
Étude pronostique
Limites du sujet:
Humains
/
Mâle
Pays comme sujet:
Amérique du Sud
/
Brésil
langue:
Anglais
Texte intégral:
Int. braz. j. urol
Thème du journal:
Urologie
Année:
2019
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Clinica AMO/BR
/
Faculdade de Medicina do ABC/BR
/
Grupo SONHE/BR
/
Hospital Beneficência Portuguesa de São Paulo/BR
/
Hospital Israelita Albert Einstein/BR
/
Hospital Mater Dei/BR
/
Hospital Sírio-Libanês/BR
/
Instituto do Câncer do Estado de São Paulo/BR
/
Oncocentro/BR
/
Pontificia Universidade Católica do Rio Grande do Sul - PUC RS/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS